[-] Show simple item record

dc.contributor.authorPersons, Robert K.eng
dc.contributor.authorNichols, Williameng
dc.date.issued2007-09eng
dc.description.abstractOnly 1 appetite stimulate, megestrol acetate oral suspension (Megace) at 400 mg or 800 mg daily, has been studied in this population. The data show only limited benefit, mixed outcomes, and potential harm (strength of recommendation: B, based on small, randomized, controlled trials).eng
dc.identifier.citationJournal of Family Practice, 56(9) 2007: 761-762.eng
dc.identifier.urihttp://hdl.handle.net/10355/3629eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofClinical Inquiries, 2007 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectmalnourished patientseng
dc.subjectadverse outcomeseng
dc.subjectquality of lifeeng
dc.subjectweight gaineng
dc.subject.lcshAppetite stimulantseng
dc.subject.lcshAppetite -- Effect of drugs oneng
dc.subject.lcshFrail elderlyeng
dc.titleShould we use appetite stimulants for malnourished elderly patients?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record